Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Mochida Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Mochida Pharmaceutical had annual revenue of 116.95B JPY with 11.21% growth. Mochida Pharmaceutical had revenue of 29.46B in the quarter ending March 31, 2026, with 20.62% growth.

• Revenue: 116.95B
• Revenue Growth: +11.21%
• P/S Ratio: 1.05
• Revenue / Employee: 77.55M
• Employees: 1,508
• Market Cap: 122.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	116.95B	11.79B	11.21%
Mar 31, 2025	105.16B	2.27B	2.21%
Mar 31, 2024	102.89B	-376.00M	-0.36%
Mar 31, 2023	103.26B	-6.92B	-6.28%
Mar 31, 2022	110.18B	7.18B	6.98%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error